• Login
    View Item 
    •   RD&E Research Repository Home
    • All RD&E publications by year
    • 2014 RD&E publications
    • View Item
    •   RD&E Research Repository Home
    • All RD&E publications by year
    • 2014 RD&E publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    TSH levels and risk of miscarriage in women on long-term levothyroxine: a community-based study

    Thumbnail
    URI
    http://hdl.handle.net/11287/593824
    Author
    Taylor, P. N.
    Minassian, C.
    Rehman, A.
    Iqbal, A.
    Draman, M. S.
    Hamilton, W.
    Dunlop, D.
    Robinson, A.
    Vaidya, Bijay
    Lazarus, J. H.
    Thomas, S.
    Dayan, C. M.
    Okosieme, O. E.
    Date
    2014-10-01
    Journal
    The Journal of clinical endocrinology and metabolism
    Type
    Journal Article
    Research Support, Non-U.S. Gov't
    Publisher
    Endocrine Society
    DOI
    10.1210/jc.2014-1954
    Metadata
    Show full item record
    Abstract
    CONTEXT: Thyroid dysfunction is associated with adverse obstetric outcomes, but there is limited information on pregnancy outcomes in women established on levothyroxine. OBJECTIVE: The objective of the study was to determine the relationship between TSH levels and pregnancy outcomes in levothyroxine-treated women in a large community-based database. DESIGN: This was a historical cohort analysis. PATIENTS: Individuals with a first prescription of levothyroxine from 2001 through 2009 (n = 55 501) were identified from the UK General Practice Research Database (population 5 million). Of these, we identified 7978 women of child-bearing age (18-45 y) and 1013 pregnancies in which levothyroxine had been initiated at least 6 months before conception. MAIN OUTCOME MEASURES: TSH, miscarriage/delivery status, and obstetric outcomes were measured. RESULTS: Forty-six percent of levothyroxine-treated women aged 18-45 years had a TSH level greater than 2.5 mU/L (recommended upper level in the first trimester). Among pregnant women who had their TSH measured in the first trimester, 62.8% had a TSH level greater than 2.5 mU/L, with 7.4% greater than 10 mU/L. Women with TSH greater than 2.5 mU/L in the first trimester had an increased risk of miscarriage compared with women with TSH 0.2-2.5 mU/L after adjusting for age, year of pregnancy, diabetes, and social class (P = .008). The risk of miscarriage was increased in women with TSH 4.51-10 mU/L [odds ratio (OR) 1.80, 95% confidence interval (CI) 1.03, 3.14)] and TSH greater than 10 mU/L (OR 3.95, 95% CI 1.87, 8.37) but not with TSH 2.51-4.5 mU/L (OR 1.09, 95% CI 0.61, 1.93). CONCLUSIONS: The majority of levothyroxine-treated women have early gestational TSH levels above the recommended targets (>2.5 mU/L) with a strong risk of miscarriage at levels exceeding 4.5 mU/L. There is an urgent need to improve the adequacy of thyroid hormone replacement in early pregnancy.
    Citation
    J Clin Endocrinol Metab. 2014 Oct;99(10):3895-902.
    Publisher URL
    http://press.endocrine.org/doi/10.1210/jc.2014-1954?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
    Collections
    • 2014 RD&E publications
    • Diabetes/Endocrine Services

    Browse

    All of RD&E Research RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    DSpace software copyright © 2002-2021  DuraSpace
    Contact Us | Send Feedback
    DSpace Express is a service operated by 
    Atmire NV